Citius Pharmaceuticals Stock Price History
CTXR Stock | USD 2.83 0.04 1.43% |
If you're considering investing in Citius Stock, it is important to understand the factors that can impact its price. As of today, the current price of Citius Pharmaceuticals stands at 2.83, as last reported on the 31st of January, with the highest price reaching 2.90 and the lowest price hitting 2.60 during the day. Citius Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. Citius Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Citius Pharmaceuticals' Standard Deviation of 9.55, risk adjusted performance of (0.11), and Mean Deviation of 6.64 to double-check the risk estimate we provide.
Citius Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Citius |
Sharpe Ratio = -0.1429
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CTXR |
Estimated Market Risk
9.55 actual daily | 85 85% of assets are less volatile |
Expected Return
-1.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Citius Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Citius Pharmaceuticals by adding Citius Pharmaceuticals to a well-diversified portfolio.
Citius Pharmaceuticals Stock Price History Chart
There are several ways to analyze Citius Stock price data. The simplest method is using a basic Citius candlestick price chart, which shows Citius Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 12, 2024 | 12.06 |
Lowest Price | December 19, 2024 | 2.57 |
Citius Pharmaceuticals January 31, 2025 Stock Price Synopsis
Various analyses of Citius Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Citius Stock. It can be used to describe the percentage change in the price of Citius Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Citius Stock.Citius Pharmaceuticals Price Rate Of Daily Change | 1.01 | |
Citius Pharmaceuticals Price Daily Balance Of Power | 0.13 | |
Citius Pharmaceuticals Price Action Indicator | 0.10 |
Citius Pharmaceuticals January 31, 2025 Stock Price Analysis
Citius Stock Price History Data
The price series of Citius Pharmaceuticals for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 9.49 with a coefficient of variation of 53.88. The prices are distributed with arithmetic mean of 4.39. The median price for the last 90 days is 3.52. The company had 1:15 stock split on 9th of June 2017. Citius Pharmaceuticals issued dividends on 2017-06-09.Open | High | Low | Close | Volume | ||
01/31/2025 | 2.83 | 2.90 | 2.60 | 2.83 | ||
01/30/2025 | 2.83 | 2.90 | 2.60 | 2.83 | 101,271 | |
01/29/2025 | 2.88 | 3.05 | 2.70 | 2.79 | 117,997 | |
01/28/2025 | 3.02 | 3.13 | 2.80 | 2.91 | 109,723 | |
01/27/2025 | 3.27 | 3.35 | 3.02 | 3.02 | 88,854 | |
01/24/2025 | 3.02 | 3.40 | 3.02 | 3.30 | 165,492 | |
01/23/2025 | 3.12 | 3.18 | 3.00 | 3.15 | 50,833 | |
01/22/2025 | 3.26 | 3.26 | 3.11 | 3.15 | 76,321 | |
01/21/2025 | 3.25 | 3.29 | 3.14 | 3.25 | 61,389 | |
01/17/2025 | 3.28 | 3.31 | 3.13 | 3.30 | 78,395 | |
01/16/2025 | 3.27 | 3.44 | 3.13 | 3.26 | 106,853 | |
01/15/2025 | 3.64 | 3.69 | 3.31 | 3.40 | 73,908 | |
01/14/2025 | 3.43 | 3.73 | 3.38 | 3.56 | 109,439 | |
01/13/2025 | 3.66 | 3.75 | 3.43 | 3.49 | 118,400 | |
01/10/2025 | 3.76 | 3.82 | 3.55 | 3.63 | 85,165 | |
01/08/2025 | 3.91 | 3.99 | 3.61 | 3.71 | 193,936 | |
01/07/2025 | 3.92 | 4.43 | 3.92 | 4.37 | 180,771 | |
01/06/2025 | 3.97 | 4.10 | 3.86 | 3.91 | 102,416 | |
01/03/2025 | 3.86 | 4.14 | 3.75 | 3.98 | 156,355 | |
01/02/2025 | 3.95 | 4.51 | 3.70 | 3.88 | 234,276 | |
12/31/2024 | 4.05 | 5.95 | 3.97 | 4.00 | 1,100,150 | |
12/30/2024 | 3.75 | 4.40 | 3.40 | 3.91 | 378,134 | |
12/27/2024 | 3.35 | 3.73 | 3.24 | 3.68 | 185,955 | |
12/26/2024 | 3.15 | 3.35 | 3.05 | 3.31 | 103,801 | |
12/24/2024 | 2.89 | 3.16 | 2.89 | 3.13 | 71,299 | |
12/23/2024 | 2.59 | 3.04 | 2.59 | 2.91 | 132,072 | |
12/20/2024 | 2.51 | 2.74 | 2.48 | 2.60 | 100,053 | |
12/19/2024 | 2.53 | 2.68 | 2.47 | 2.57 | 55,930 | |
12/18/2024 | 2.72 | 2.79 | 2.44 | 2.59 | 139,612 | |
12/17/2024 | 2.58 | 2.85 | 2.44 | 2.73 | 131,316 | |
12/16/2024 | 2.78 | 2.84 | 2.58 | 2.58 | 163,420 | |
12/13/2024 | 2.86 | 2.89 | 2.65 | 2.79 | 113,029 | |
12/12/2024 | 3.00 | 3.10 | 2.77 | 2.86 | 117,179 | |
12/11/2024 | 3.24 | 3.31 | 2.93 | 3.06 | 123,327 | |
12/10/2024 | 3.35 | 3.38 | 3.17 | 3.27 | 67,997 | |
12/09/2024 | 3.54 | 3.58 | 3.29 | 3.32 | 118,205 | |
12/06/2024 | 3.66 | 3.69 | 3.35 | 3.52 | 109,889 | |
12/05/2024 | 3.65 | 3.80 | 3.53 | 3.66 | 110,114 | |
12/04/2024 | 3.48 | 3.75 | 3.15 | 3.64 | 172,862 | |
12/03/2024 | 3.34 | 3.84 | 3.26 | 3.55 | 336,953 | |
12/02/2024 | 3.31 | 3.32 | 2.98 | 3.22 | 279,684 | |
11/29/2024 | 3.49 | 3.60 | 3.26 | 3.32 | 180,476 | |
11/27/2024 | 3.60 | 4.11 | 3.50 | 3.60 | 421,063 | |
11/26/2024 | 3.58 | 4.25 | 2.55 | 4.15 | 1,728,526 | |
11/25/2024 | 4.60 | 4.61 | 3.28 | 3.34 | 5,907,752 | |
11/22/2024 | 3.35 | 3.75 | 2.74 | 3.35 | 645,576 | |
11/21/2024 | 4.24 | 4.50 | 3.82 | 4.13 | 183,653 | |
11/20/2024 | 5.00 | 5.22 | 4.00 | 4.25 | 169,908 | |
11/19/2024 | 5.73 | 5.73 | 4.73 | 4.80 | 156,571 | |
11/18/2024 | 5.05 | 6.11 | 4.76 | 5.61 | 505,692 | |
11/15/2024 | 7.96 | 8.20 | 4.69 | 5.00 | 450,551 | |
11/14/2024 | 8.23 | 9.35 | 6.32 | 8.21 | 220,953 | |
11/13/2024 | 12.25 | 12.25 | 9.38 | 9.64 | 97,020 | |
11/12/2024 | 11.75 | 12.84 | 11.38 | 12.06 | 113,592 | |
11/11/2024 | 11.48 | 12.23 | 10.29 | 11.23 | 174,634 | |
11/08/2024 | 10.43 | 11.03 | 9.87 | 10.29 | 97,030 | |
11/07/2024 | 9.03 | 10.49 | 9.03 | 9.56 | 120,630 | |
11/06/2024 | 8.75 | 9.15 | 7.75 | 8.68 | 29,835 | |
11/05/2024 | 8.63 | 9.00 | 8.53 | 8.74 | 14,238 | |
11/04/2024 | 9.00 | 9.25 | 8.63 | 8.73 | 21,452 | |
11/01/2024 | 9.30 | 9.46 | 8.84 | 8.97 | 21,735 |
About Citius Pharmaceuticals Stock history
Citius Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Citius is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Citius Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Citius Pharmaceuticals stock prices may prove useful in developing a viable investing in Citius Pharmaceuticals
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. Citius Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Citius Pharmaceuticals Stock Technical Analysis
Citius Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
All Next | Launch Module |
Citius Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Citius Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Citius Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Citius to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.11) | |||
Jensen Alpha | (1.48) | |||
Total Risk Alpha | (2.40) | |||
Treynor Ratio | (1.21) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Citius Stock Analysis
When running Citius Pharmaceuticals' price analysis, check to measure Citius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Pharmaceuticals is operating at the current time. Most of Citius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Citius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Citius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.